BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Diagnosis
28 results:

  • 1. Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
    Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
    Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression.
    Hindi N; Carrillo-García J; Blanco-Alcaina E; Renshaw M; Luna P; Durán J; Jiménez N; Sancho P; Ramos R; Moura DS; Martín-Broto J
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614297
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
    Jagosky MH; Anderson CJ; Symanowski JT; Steuerwald NM; Farhangfar CJ; Baldrige EA; Benbow JH; Livingston MB; Patt JC; Ahrens WA; Kneisl JS; Kim ES
    Cancer Med; 2023 Mar; 12(6):7029-7038. PubMed ID: 36464833
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.
    Hu W; Yuan L; Zhang X; Ni Y; Hong D; Wang Z; Li X; Ling Y; Zhang C; Deng W; Tian M; Ding R; Song C; Li J; Zhang X
    Cancer Sci; 2022 May; 113(5):1843-1854. PubMed ID: 35238118
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Paratesticular liposarcoma: the clinicopathological features of nineteen cases].
    Yang SM; Wu RC; Qi SS; You JF
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):17-22. PubMed ID: 34979748
    [No Abstract]    [Full Text] [Related]  

  • 7. Clinical Application of Chromosome Microarray Analysis in the diagnosis of lipomatous Tumors.
    Pei J; Flieder DB; Talarchek JN; Cooper HS; Patchefsky AS; Wei S
    Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):592-598. PubMed ID: 33734108
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.
    Arias-Stella JA; Benayed R; Oliva E; Young RH; Hoang LN; Lee CH; Jungbluth AA; Frosina D; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 Mar; 43(3):382-388. PubMed ID: 30489320
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline
    Thibodeau ML; Reisle C; Zhao E; Martin LA; Alwelaie Y; Mungall KL; Ch'ng C; Thomas R; Ng T; Yip S; J Lim H; Sun S; Young SS; Karsan A; Zhao Y; Mungall AJ; Moore RA; J Renouf D; Gelmon K; Ma YP; Hayes M; Laskin J; Marra MA; Schrader KA; Jones SJM
    Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28514723
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
    Lu B; Shi H; Zhang X
    Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Role of Immunohistochemistry in Rhabdomyosarcoma diagnosis Using Tissue Microarray Technology and a Xenograft Model.
    Machado I; Mayordomo-Aranda E; Giner F; Llombart-Bosch A
    Fetal Pediatr Pathol; 2015; 34(5):271-81. PubMed ID: 26125949
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeted genomic analysis of Müllerian adenosarcoma.
    Howitt BE; Sholl LM; Dal Cin P; Jia Y; Yuan L; MacConaill L; Lindeman N; Kuo F; Garcia E; Nucci MR; Quade BJ
    J Pathol; 2015 Jan; 235(1):37-49. PubMed ID: 25231023
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification.
    Panagopoulos I; Bjerkehagen B; Gorunova L; Berner JM; Boye K; Heim S
    Int J Oncol; 2014 Nov; 45(5):1829-36. PubMed ID: 25176350
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Can hmgi-c be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
    Alshenawy H
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Value and limitation of immunohistochemical expression of hmga2 in mesenchymal tumors: about a series of 1052 cases.
    Dreux N; Marty M; Chibon F; Vélasco V; Hostein I; Ranchère-Vince D; Terrier P; Coindre JM
    Mod Pathol; 2010 Dec; 23(12):1657-66. PubMed ID: 20834238
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.
    Erickson-Johnson MR; Seys AR; Roth CW; King AA; Hulshizer RL; Wang X; Asmann YW; Lloyd RV; Jacob EK; Oliveira AM
    Mod Pathol; 2009 Dec; 22(12):1541-7. PubMed ID: 19820690
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Retroperitoneal lipomatous tumors without cytologic atypia: are they lipomas? A clinicopathologic and molecular study of 19 cases.
    Macarenco RS; Erickson-Johnson M; Wang X; Folpe AA; Rubin BP; Nascimento AG; Oliveira AM
    Am J Surg Pathol; 2009 Oct; 33(10):1470-6. PubMed ID: 19654500
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
    Davicioni E; Anderson MJ; Finckenstein FG; Lynch JC; Qualman SJ; Shimada H; Schofield DE; Buckley JD; Meyer WH; Sorensen PH; Triche TJ
    Am J Pathol; 2009 Feb; 174(2):550-64. PubMed ID: 19147825
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of hmga2 in malignant peripheral nerve sheath tumor.
    Hui P; Li N; Johnson C; De Wever I; Sciot R; Manfioletti G; Tallini G
    Mod Pathol; 2005 Nov; 18(11):1519-26. PubMed ID: 16056249
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Malignant fibrous histiocytoma: pleomorphic sarcoma NOS or pleomorphic fibrosarcoma].
    Meister P
    Pathologe; 2005 Mar; 26(2):127-33. PubMed ID: 15702318
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.